Food and Nutritional Products in the Consumer Marketplace
The Weight Control Industry
MEDICAL CONDITIONS MOST LIKELY TO REQUIRE NUTRITIONAL SUPPORT
Table Disease States That Benefit Most from Nutritional Supplementation
Table Distribution of Patients Currently Using Long-Term Nutritional Supplementation in the Home or Long-Term Setting Percentage of Total by Condition and Type of Supplementation (Enteral vs Parenteral)
Nutrition Support in the Dying Patient
Nutritional Management in Chylous Leaks
Acquired Immune Deficiency Syndrome
Nutritional Support in Burn Injury
Methods of Nutritional Support
CHOOSING A METHOD FOR NUTRITIONAL SUPPORT
Strategies for Tube Feeding
Table Indications and Contraindications for Enteral Feeding
Table Disease-Specific Enteral Nutrition for Inborn Errors of Metabolism
Hormone Response to Enteral Feeding and Choice of Materials
Products Used for Enteral Feeding
Management of Enteral Feeding
Table Conditions for Which Parenteral May Be Indicated
Total Parenteral Nutrition
Table Advantages and Disadvantages of TPN
Table AMA Recommendations for Use of TPN
Medical Nutrition Market and Forecasts
SUMMARY OF NUTRITIONAL PRODUCTS AND PROCEDURES
Enteral Nutritional Support
Advantages of Nutritional Support
FACTORS CONTRIBUTING TO A CHANGING MEDICAL NUTRITION MARKET
An Ageing Patient Population
Table Number of Patients using Medical Nutritional Supplements by Product Type 2001-2008
Greater Emphasis on Weight Control
Health Care Insurance
Home Care and Alternate Site Care
Table Important Growth Factors Affecting the Parenteral Nutrition Solution Market
Table Important Restrictions Affecting to the Parenteral Nutrition Solution Market
MARKET SIZE AND FORECASTS
Segmentation by Type of Facility
Table The U.S. Market for Enteral and Parenteral Nutritional Supplements by Type of Facility (Home/Alternate Site vs Hospital/Acute Care) 2001-2008
Segmentation by Type of Route of Administration
Table The U.S. Market for Enteral and Parenteral Nutritional Supplements by Route of Administration (Oral Enteral, Enteral Tube, Parenteral) 2001-2008
Company & Organization Profiles
ALARIS MEDICAL SYSTEMS, INC..
AMERICAN GASTROENTEROLOGICAL ASSOCIATION
AMERICAN HOMEPATIENT, INC.
AMERICAN SOCIETY FOR PARENTERAL & ENTERAL NUTRITION (ASPEN)
B. BRAUN MEDICAL INC.
BAXTER INTERNATIONAL INC.
BRISTOL-MYERS SQUIBB COMPANY
FUJISAWA PHARMACEUTICAL COMPANY, LTD.
HOSPIRA INC. (SUBSIDIARY OF ABBOTT LABORATORIES)
KENDALL HEALTHCARE PRODUCTS
MEAD JOHNSON NUTRITIONAL GROUP (A SUBSIDIARY OF BRISTOL-MYERS SQUIBB)
NOVARTIS MEDICAL NUTRITION
ROSS PRODUCTS DIVISION OF ABBOTT LABORATORIES
SHS NORTH AMERICA
ZEVEX INTERNATIONAL, INC.
The Market for Clinical Nutritional Products Description
This market briefing concentrates on the U.S. market for medical nutritional support—in particular, the enteral and parenteral foods. The continuing development of equipment, medical foods, and feeding procedures that secure the nutrition of critically ill patents has greatly improved recovery and survival in select populations. Advances in the effectiveness and safety of nutritional procedures and techniques have evolved from steady improvements, including the use of antibiotic materials, biosensors, wireless communications, and more efficient pumps and controllers. These new developments have stabilized the market and maintained a consistent market competition. Increasingly favorable epidemiology and demographics make the outlook for additional applications and concomitant market growth quite good. Growth and development of ancillary markets in nutritional supplementation, both consumer driven and clinical, are also building interest in this sector.
In addition to a thorough discussion of the drivers and constraints in the current market, the briefing provides forecasts through 2008 for the following market data:
Number of patients using medical nutritional supplements by product type (oral enteral, enteral tube, parenteral)
Revenues for enteral and parenteral nutritional supplements by type of facility (home/alternate site vs hospital/acute care)
Revenues for enteral and parenteral nutritional supplements by route of administration (oral enteral, enteral tube, parenteral)
Market data and forecasts are based on an examination of current market conditions, current and projected demographics, and on investigations into the development of new products by key companies. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with various stakeholders in the clinical nutrition industry, including company executives, clinicians, insurers, regulators, researchers, and public health officials.